作者:Bireshwar Dasgupta、Edward Kozlowski、Daniel R. Schroeder、John R. Torrente、Cen Xu、Sokhom Pin、Charlie M. Conway、Gene M. Dubowchik、John E. Macor、Vivekananda M. Vrudhula
DOI:10.1016/j.bmcl.2014.04.033
日期:2014.6
An oxidation product (5) formed during the synthesis of BIBN-4096BS (1) was found to be a potent CGRP antagonist (IC50 = 0.11 nM). While 5 was found to be ten-fold less potent than 1, another analog 8 with lower molecular weight containing the oxidized fragment demonstrated twenty-fold higher activity than its parent 7. Alternative conditions which preclude the formation of the oxidation product are described. The activities of 1, 5, 7 and 8 in functional cAMP assay are also discussed. (C) 2014 Elsevier Ltd. All rights reserved.